CD8+ epidermotropic cytotoxic T-cell lymphoma with peripheral blood and central nervous system involvement

Archives of Dermatology

Volumn 144, Issue 8, 2008, Pages 1027-1029

  Introcaso, Camille E ^a   Kim, Ellen J ^a   Gardner, Jennifer ^a   Junkins Hopkins, Jacqueline M ^a   Vittorio, Carmela C ^a   Rook, Alain H ^a  

^a HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BEXAROTENE; CD4 ANTIGEN; CD7 ANTIGEN; CD8 ANTIGEN; CHLORMETHINE; DIPEPTIDYL PEPTIDASE IV; PSORALEN; T LYMPHOCYTE RECEPTOR;

AGED; ARTICLE; BLOOD ANALYSIS; BLOOD DISEASE; CANCER DIAGNOSIS; CASE REPORT; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROSPINAL FLUID; CEREBROSPINAL FLUID ANALYSIS; CUTANEOUS T CELL LYMPHOMA; DISEASE COURSE; DISEASE SEVERITY; DRUG WITHDRAWAL; ELECTRON THERAPY; FEMALE; FLOW CYTOMETRY; GENE REARRANGEMENT; HUMAN; HUMAN TISSUE; LABORATORY TEST; MENINGISM; MOLECULAR CLONING; MOLECULAR GENETICS; PHENOTYPE; PRIORITY JOURNAL; PUVA; RECEPTOR GENE; SKIN BIOPSY; T LYMPHOCYTE SUBPOPULATION;

AGED; ANTIGENS, CD; CENTRAL NERVOUS SYSTEM NEOPLASMS; CEREBROSPINAL FLUID; FEMALE; FLOW CYTOMETRY; GENE REARRANGEMENT, T-LYMPHOCYTE; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA; LYMPHOMA, T-CELL, CUTANEOUS; PROGNOSIS; SKIN; SKIN NEOPLASMS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 49949091563     PISSN: 0003987X     EISSN: 0003987X     Source Type: Journal    
DOI: 10.1001/archderm.144.8.1027     Document Type: Article

References (8)

1. Olsen E, Vonderheid E, Pimpinelli N, et al; ISCL/EORTC. Revisions to the staging and classification of mycosis fungoides and Sézary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC) [published online ahead of print May 31, 2007]. Blood. 2007;110 (6):1713-1722. doi: 10.1182/blood-2007-03-055749.
2. Kim EJ, Hess S, Richardson S, et al. Immunopathogenesis and therapy of cutaneous T cell lymphoma. J Clin Invest. 2005;115(4):798-812.
3. + T cell phenotype. Am J Surg Pathol. 2002;26(4):450-457.
4. + epidermotropic cytotoxic primary cutaneous T-cell lymphoma with multiorgan involvement. Dermatology. 2005;211(3):281-285.
5. Berti E, Tomasini D, Vermeer MH, Meijer CJ, Alessi E, Willemze R. Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas: a distinct clinicopathological entity with an aggressive clinical behavior. Am J Pathol. 1999;155(2):483-492.
6. Willemze R, Jaffe E, Burg G, et al. WHO-EORTC classification for cutaneous lymphomas. Blood. 2005;105(10):3768-3785.
7. + CD26- subset in the identification of circulating Sezary cell. Br J Dermatol. 2001;144(1):125-135.
8. +CD7- immunophenotype in patients with benign and malignant lymphoproliferative dermatoses. J Am Acad Dermatol. 1996;35(3, pt 1):404-410.